Strides Arcolab Gets U.S. Approval for Doxorubicin Injection

Onco Therapies Ltd., a unit of Indian drugmaker Strides Arcolab Ltd. (STR), received approval from the U.S. Food and Drug Administration for its doxorubicin chemotherapy injection, according to a statement on the FDA website.

To contact the reporter on this story: Adi Narayan in Mumbai at anarayan8@bloomberg.net

To contact the editor responsible for this story: Hari Govind at hgovind@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.